Obsidian Therapeutics Company
Obsidian Therapeutics is a developer of a next-generation cell and gene therapies created to extend adoptive immunotherapy.
Connections from
Total Funding:
164500000
Last Funding Type:
Series B
Founded Date:
1/1/2015
Industry:
Gene therapy
Employee Number:
51-100
Funding Status:
Early Stage Venture
Headquarters:
Cambridge, Massachusetts, United States